Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;24(6):787-90.
doi: 10.1097/EDE.0b013e3182a6d9aa.

Immortal time bias in the study of stillbirth risk factors: the example of gestational diabetes

Affiliations

Immortal time bias in the study of stillbirth risk factors: the example of gestational diabetes

Jennifer A Hutcheon et al. Epidemiology. 2013 Nov.

Erratum in

  • Epidemiology. 2015 Jan;26(1):e13

Abstract

Background: Current understanding of the increased risk for stillbirth in gestational diabetes mellitus is often based on large cohort studies in which the risk of stillbirth in women with this disease is compared with the risk in women without. However, such studies could be susceptible to immortal time bias because, although many cohorts begin at 20 weeks' gestation, pregnancies must "survive" until 24-28 weeks in order to be screened and diagnosed with gestational diabetes.

Methods: We describe the theoretical potential for immortal time bias in studies of stillbirth and gestational diabetes and then quantify the magnitude of the bias using 2006 United States vital statistics data.

Results: Although gestational diabetes was protective against stillbirth when including all births (relative risk = 0.88 [95% confidence interval = 0.79-0.99]), restricting analyses to births at >28 weeks' gestation reversed the effect and diabetes became associated with an increased risk of stillbirth (1.25 [1.11-1.41]).

Conclusion: Immortal time before diagnosis of gestational diabetes may bias our understanding of the stillbirth risk associated with this condition.

PubMed Disclaimer

Comment in

  • Diabetes in Pregnancy.
    Berger H, Gagnon R, Sermer M, Basso M, Bos H, Brown RN, Bujold E, Cooper SL, Gagnon R, Gouin K, McLeod NL, Menticoglou SM, Mundle WR, Roggensack A, Sanderson FL, Walsh JD. Berger H, et al. J Obstet Gynaecol Can. 2016 Jul;38(7):667-679.e1. doi: 10.1016/j.jogc.2016.04.002. Epub 2016 May 12. J Obstet Gynaecol Can. 2016. PMID: 27591352

Publication types

LinkOut - more resources